ORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadade... 09/09/2024 Healthcare Innovative drugs Exploring the triple combination with venetoclax and azacitidine. Study sponsored by Oregon Health & Science University... Partners - Oryzon Genomics
ORYZON continues to strengthen its patent portfolio for vafidemstat with additional “Decis... 03/09/2024 Healthcare Rare diseases Innovative drugs In Australia, Malaysia and Mexico. Partners - Oryzon Genomics
Vaxdyn awarded €14.5 Million from the EIC Accelerator to Fund the Clinical Phase of Its Va... 02/09/2024 Healthcare Access to innovation Innovative drugs Antibiotic resistance The European Commission is committed to combating antibiotic resistance through vaccines, selecting Vaxdyn's competitive... Partners - Vaxdyn
AbilityPharma receives WHO approval for its ABTL0812 anticancer drug to be named IBRILATAZ... 08/08/2024 Healthcare Innovative drugs ABTL0812 has been given the International Non-proprietary Designation (INN) ibrilatazar on the recommended list of INNs... Partners - Ability Pharmaceuticals
Peaches Biotech ready to enter into the production of biological medicines with the Histok... 06/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies The Madrid-based laboratory, together with Histocell and Cardiva, has launched Histokine, located in the Basque Country... Partners - PEACHES BIOTECH S.L.
ORYZON reports financial results and corporate update for half-year ending June 30, 2024 01/08/2024 Healthcare Access to innovation Innovative drugs Advanced therapies Research and development (R&D) expenses of $4.9m for the half-year ending June 30, 2024. As a result of the completion... Partners - Oryzon Genomics
What is Open Innovation in pharmaceutical R&D? 18/07/2024 Healthcare Access to innovation Drug discovery Innovative drugs The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers... Partners - GENESIS Biomed
#AseBioInterview | This has been the development process of the first vaccine against Epiz... 17/07/2024 Healthcare Innovative drugs Agrifood Animal health "Currently, the outbreak of EHDV serotype 8 is generating great alarm due to its epidemic potential and the absence of a... AseBio - Zendal
ORYZON receives “Decision to grant” for two important patents for vafidemstat in Japan 08/07/2024 Healthcare Innovative drugs For the treatment of Borderline Personality Disorder (BPD) and Attention Deficit Hyperactivity disorder (ADHD). Partners - Oryzon Genomics
Juan Basterra (Mikrobiomik) | "In the last 10 years, decisive steps have been taken to und... 27/06/2024 Healthcare Drug discovery Innovative drugs Mikrobiomik is working to become the first company globally to market the first biological drug based on gut microbiota... AseBio - Mikrobiomik
